BBH vs. LWDB, TFG, FCSS, ASL, EDIN, JMG, GSS, FSV, IHP, and BBGI
Should you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include Law Debenture (LWDB), Tetragon Financial (TFG), Fidelity China Special (FCSS), Aberforth Smaller Companies Trust (ASL), Edinburgh Investment (EDIN), JPMorgan Emerging Markets (JMG), Genesis Emerging Markets Fund (GSS), Fidelity Investment Trust - Fidelity Special Values (FSV), IntegraFin (IHP), and BBGI Global Infrastructure (BBGI). These companies are all part of the "asset management" industry.
Bellevue Healthcare vs.
Bellevue Healthcare (LON:BBH) and Law Debenture (LON:LWDB) are both small-cap financial services companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, community ranking, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.
Bellevue Healthcare received 32 more outperform votes than Law Debenture when rated by MarketBeat users. Likewise, 68.52% of users gave Bellevue Healthcare an outperform vote while only 64.75% of users gave Law Debenture an outperform vote.
Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 5.2%. Law Debenture pays an annual dividend of GBX 32 per share and has a dividend yield of 3.7%. Bellevue Healthcare pays out -91.3% of its earnings in the form of a dividend. Law Debenture pays out 29.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Bellevue Healthcare is clearly the better dividend stock, given its higher yield and lower payout ratio.
In the previous week, Bellevue Healthcare had 1 more articles in the media than Law Debenture. MarketBeat recorded 2 mentions for Bellevue Healthcare and 1 mentions for Law Debenture. Law Debenture's average media sentiment score of 0.59 beat Bellevue Healthcare's score of 0.34 indicating that Law Debenture is being referred to more favorably in the news media.
40.6% of Bellevue Healthcare shares are held by institutional investors. Comparatively, 9.3% of Law Debenture shares are held by institutional investors. 0.1% of Bellevue Healthcare shares are held by company insiders. Comparatively, 6.3% of Law Debenture shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Law Debenture has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than Law Debenture, indicating that it is currently the more affordable of the two stocks.
Bellevue Healthcare has a net margin of 169.10% compared to Law Debenture's net margin of 69.85%. Law Debenture's return on equity of 15.91% beat Bellevue Healthcare's return on equity.
Summary
Law Debenture beats Bellevue Healthcare on 9 of the 16 factors compared between the two stocks.
Get Bellevue Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Bellevue Healthcare Competitors List
Related Companies and Tools
This page (LON:BBH) was last updated on 4/22/2025 by MarketBeat.com Staff
Buy BBH Stock Free BBH Stock Alerts